Search Results

Partenariat Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer à modifier le contenu et assurez-vous d'ajouter tous les détails ou informations pertinents que vous souhaitez partager avec vos visiteurs. Bouton Our Business Units AcedrA is a regional leader in medical innovation, driven by three business units that focus on unmet needs and unique opportunities. Our Unmet Medical Needs business unit specializes in identifying diseases with no available treatments and working to make accessible groundbreaking therapies. The Unmet Commercial Needs unit explores new ways to improve existing methods of care, making treatments more accessible and affordable. Finally, in our Medical Technology unit, we are dedicated to leveraging new technologies to improve patient outcomes and reduce healthcare costs. With advances in all three areas, AcedrA is poised to revolutionize the way medical treatments are delivered around the Middle East & North Africa region. Discover Access Sourcing AcedrA is on a mission to bridge the gap between drug supply and demand, ensuring quality healthcare for all. With our global network of more than 100 suppliers, we are able to provide reliable access to essential medications at competitive prices - breaking down geographical and economic barriers that have previously limited access to treatments. We believe that everyone has a right to quality healthcare! We are committed to making this innovative service available at all times and believe that no one should have to worry about their health due to a lack of access or affordability. With AcedrA, you can put your trust in us for all of your medication needs. Discover Access Innovation AcedrA is revolutionizing the healthcare sector in the MENA region. Bridging with innovative Biotech and MedTech companies, AcedrA aims to reduce the time-to-market for advanced therapeutics and treatments. This translates into a world of possibilities for healthcare professionals, scientific societies, patient communities, and beyond. With access to the latest cutting-edge technology, these individuals and organizations can now stay ahead of the curve, offering enhanced solutions that benefit everyone. AcedrA is making it possible for healthcare professionals to provide better care, and provide patients with access to more advanced treatments. This is a game-changer in the MENA region! Join us as we take healthcare to the next level. Discover Our Therapeutic Areas At AcedrA, we specialize in delivering, distributing, and even co-developing innovative treatments for conditions with unmet medical needs. Our cutting-edge expert team is dedicated to uncovering novel therapeutics that can make life easier for patients across the MENA region who are facing complex cases with limited options. We believe that progress starts here: by taking on today's toughest medical challenges with courage, creativity, and a commitment to excellence. Together, we can make a difference and revolutionize healthcare for everyone. Join us in our mission to provide hope and life-changing solutions. Discover Develop Passionately AcedrA is the go-to partner for Pharmaceutical, Biotech, and Medtech companies in the MENA region looking for value-adding partnerships that will drive their business forward. With AcedrA, you can rest assured that your business development goals will be achieved quickly and efficiently. Business Development AcedrA Institute AcedrA Institute is a comprehensive educational platform that offers healthcare professionals access to the latest news, insights, and research related to the medical field. The platform provides access to curated articles, cutting-edge research studies, and market intelligence from around the world. Our mission is to make sure that healthcare professionals are informed about the latest trends in their field and are equipped to make decisions that can improve patient outcomes. Enjoy Commercial Excellence Business Units

Bonjour Ceci est votre page À propos. C'est une excellente occasion de donner un aperçu complet de qui vous êtes, de ce que vous faites et de ce que votre site Web a à offrir. Double-cliquez sur la zone de texte pour commencer à modifier votre contenu et assurez-vous d'ajouter tous les détails pertinents que vous souhaitez partager avec les visiteurs du site. Discover our Capabilities +1600 operations Till today AcedrA has succeeded in importing and exporting more than 1600 operations with a Business Success Rate of 98%. In full compliance with international GDP and GSP and local guidelines for importing health products. Discover our Capabilities We deliver Ex cellence AcedrA is an innovative and trusted logistics and distribution partner in the Middle East and North Africa region. With a successful track record of experience, we promise to deliver excellence in all aspects of our supply chain operations. +40,000 patients More than 40 thousand patients took benefits from our medications and devices with a string pharmacovigilance system ensuring good monitoring and avoiding any probability of discontinuation in their treatments. Discover our Capabilities We deliver Care We have developed a comprehensive distribution and supply chain network that ensures our products are available wherever they are needed. Our innovative approach makes sure that we can provide essential healthcare solutions to those who need them most. With AcedrA, you can rest assured that you will always have access to the care you need. +160 customers More than 160 hospitals and healthcare institutions received with an ultimatum level of satisfaction our deliveries. Located on 2 continents, we are a qualified vendor within the most complex organizations either governmental, semi-governmental or private hopistals. Discover our Capabilities We deliver Experience We use cutting-edge technology and specialize in integrating multiple services into a single solution for the convenience and satisfaction of our clients. Whether it's transportation, warehousing, or distribution, AcedrA guarantees an efficient and cost-effective delivery process every time. +30,000,000 units We stored and delivered more than 30 million units with a wide spectrum of galenic forms like injectables, solutions, vials, injection devices, medical equipment, tablets, capsules, powders, syrups, ampoules, tubes, Discover our Capabilities We deliver Expertise AcedrA is the perfect partner to have in your corner when it comes to understanding the complexities of distribution and supply chain management within the Middle East and North Africa region. Our team of experts can help you identify potential risks, create an effective strategy for navigating those challenges, and ensure that your business is well-positioned for success across the region. Contacter Je suis toujours à la recherche de nouvelles opportunités passionnantes. Connectons-nous. info@monsite.com 123-456-7890 Regulatory & Medical Affairs Full Agency Management

Titre de la page Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer à modifier le contenu et assurez-vous d'ajouter tous les détails ou informations pertinents que vous souhaitez partager avec vos visiteurs. Bouton Section titre Petit titre Preparing and submitting regulatory submissions: Preparing and submitting documents and applications to obtain regulatory approvals and clearances, such as licenses, permits, and certifications. Petit titre Supporting product registration: Assisting in registering products and services in various countries and jurisdictions, including obtaining the necessary permits and certifications. Petit titre Monitoring and reporting on regulatory changes: Keeping abreast of changes in regulations and ensuring that products and services remain in compliance. Petit titre Facilitating inspections and audits: Preparing for and assisting with regulatory inspections and audits, and responding to regulatory questions and inquiries. Evaluate Evaluating regulatory requirements: Identifying and assessing the regulations and laws that apply to a product or service Our Expertise will unlock your Access MENA region expert When it comes to regulatory affairs in the Middle East and North Africa region, it can be a complex and challenging process. But when regulatory compliance is met and standards are upheld, businesses across the region have access to untapped potential. Our team of regulatory affairs experts helps our clients navigate the intricate regulatory frameworks of this dynamic region to ensure that their products and services meet regulatory requirements. With a deep understanding of local regulatory details, our experienced regulatory professionals provide comprehensive regulatory and compliance services that help businesses reduce risk and maximize their potential in the Middle East and North Africa region. Contact Us Our Pharmacovigilance Activities DSUR Development Safety Update Report QPPV Qualified Person for Pharmacovigilance ICSR Individual Case Safety Report LSR Local Safety Responsible PSMF Pharmacovigilance System Master File PSUR Periodic Safety Update Report PBRER Periodic Benefit-Risk Evaluation Report SUSAR Suspected Unexpected Serious Adverse Event RMP Risk Management Plan PASS Post Authorization Safety Study Ask our experts if you would like to understand the regulatory pathway. Just match the type of your product with the right service that would like to get. Wide Spectrum of Health Products New Drug Request Now Complete Regulatory Affairs Management Marketing Authorizations Request Now Contact Us Section titre Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer à modifier le contenu et assurez-vous d'ajouter tous les détails ou informations pertinents que vous souhaitez partager avec vos visiteurs. To play, press and hold the enter key. To stop, release the enter key. Si vous avez des commentaires sur la gouvernance d'AcedrA, laissez-nous un message et nous vous répondrons. Prénom Nom de famille E-mail Sujet Tapez votre message ici... Nous faire parvenir Merci d'avoir soumis ! Regional Presence Medical Support

AcedrA Terms & Conditions of Business 1. DEFINITIONS Within these conditions the following definitions shall apply: "AcedrA" shall mean AcedrA Pharmaceutical Company LLC and any AcedrA Subsidiary (as applicable). “AcedrA Subsidiary” shall mean any person that directly or indirectly is controlled by AcedrA Pharmaceutical Company LLC. “Controlled by” shall mean the power to direct or cause the direction of the management or policies of a person whether through the direct or indirect ownership of voting securities, by contract, resolution, regulation, or otherwise. "Deliverables" shall mean all documents, products, and materials developed by the Supplier or its agents, contractors, and employees as part of or in relation to the Services in any form or media. "Intellectual Property Rights" shall mean patents, rights to inventions, copyright and related rights, moral rights, trademarks and service marks, business names, and domain names, rights in get-up and trade dress, goodwill and the right to sue for passing off, rights in designs, rights in computer software, database rights, rights to use, and protect the confidentiality of, confidential information (including know-how and trade secrets), and all other intellectual property rights, in each case whether registered or unregistered and including all applications and rights to apply for and be granted, renewals or extensions of, and rights to claim priority from, such rights and all similar or equivalent rights or forms of protection which subsist or will subsist now or in the future in any part of the world. "Order" shall mean the authorized Purchase Order placed by AcedrA upon the Supplier for goods and/or services, including the conditions detailed herein and any authorized amendment thereto. "Products" shall mean all goods to be supplied under the Order, and any replaced or repaired goods provided by the Supplier pursuant to an Order. “Sanctions Laws” means any law, regulation, or wider measure applicable to either AcedrA or the Supplier relating to the adoption, implementation, and enforcement of economic sanctions, export controls, and trade embargos. “Sanctioned Person” means any individual, entity, or body (i) specifically designated under Sanctions Laws, (ii) owned or controlled by any individual, entity, or body specifically designated or listed under Sanctions Laws, or (iii) acting for or on behalf of any individual, entity or body specifically designated or listed under Sanctions Laws. "Services" shall mean all services to be supplied under the Order. "Supplier" shall mean the contracting party on whom the Order is placed. "Working Days" shall mean a day, other than a Friday, Saturday, or public holiday in Saudi Arabia when banks in Saudi Arabia are open for business. And, shall mean a day, other than Saturday, Sunday, or public holiday outside in Saudi Arabia when banks outside Saudi Arabia are open for business. 2. APPLICABLE CONDITIONS These conditions and the Order shall constitute the entire agreement between the parties and shall supersede any prior communications or representations between the parties except that in the event of any conflict between these conditions and the Order and any signed agreement between the parties, the signed agreement shall take precedence. By accepting AcedrA's Order the Supplier agrees that these conditions and the Order supersede any Conditions of Sale issued by the Supplier. All of these conditions shall apply to the supply of both Products and Services except where the application to one or the other is specified. 3. OFFICIAL ORDER No Products or Services will be accepted or paid for unless supplied in accordance with the Order. The Supplier shall reference the Order number on all correspondence entered into. Within 2 Working Days of the Order being issued, the Supplier shall sign and return a copy of the Order to confirm its acceptance. Failure to comply will result in the Order being deemed as accepted. The Supplier shall not deliver the Products in installments without AcedrA's prior written consent. Prior to accepting the Order, the Supplier will inform AcedrA if the Products must be delivered in installments and AcedrA can consent at its discretion. Where it is agreed that the Products are to be delivered in installments, they may be invoiced and paid for separately. 4. AMENDMENTS Prior to acceptance of the Order by the Supplier in accordance with clause 3, AcedrA may amend or withdraw its Order at any time. Once accepted, no variation to the Order will be recognized by AcedrA unless presented in writing and duly authorized by AcedrA in writing. 5. SPECIFICATION Once an Order is accepted by the Supplier in accordance with clause 3, all Products or Services under each Order shall conform where applicable with the quantity, quality, standard, and specification stated on the Order. All Products shall comply with all applicable statutory and regulatory requirements relating to the manufacture of the Products and shall be of satisfactory quality (within the meaning of the Saudi Food and Drug Authority Clearance Conditions & Requirements 2015 , as amended) and fit for the purpose made known to the Supplier by AcedrA expressly or by implication and free from defect whether actual or latent. Where the Supplier has provided AcedrA with a sample of the Products, the Products delivered will be of the same quality as the sample and be without defect. All Products must comply with Saudi Food and Drug Authority Regulatory Framework for Drugs Approval 2020 in order to minimize the risk of transmitting animal spongiform encephalopathy via Medical Products. All New Products ordered by AcedrA require documentation from the manufacturer confirming compliance with the Saudi Food and Drug Authority Clearance Conditions & Requirements 2015. All Products must have at least Sixty Seven Percent (67%) (2/3) of shelf life remaining as of the date of delivery to AcedrA. Failure to comply will result in non-payment unless a prior agreement has been reached with AcedrA. In the event of a product recall, the Supplier shall reimburse AcedrA for all reasonable expenses incurred in carrying out the recall. In providing the Services, the Supplier shall co-operate with and comply with all instructions of AcedrA, including requirements in the Order, and will perform the Services with the best care, skill, and diligence in accordance with best practice in the Supplier's industry, profession or trade. The Supplier shall use personnel who are suitably skilled and experienced to perform tasks assigned to them, and in sufficient numbers to ensure that the Supplier's obligations are fulfilled in accordance with the Order. 6. PACKAGING All Products under the Order shall be securely and adequately packed, and the packaging marked with AcedrA's Order number. All packaging shall be non-chargeable and non-returnable unless otherwise agreed in writing by AcedrA whereupon it may be returned at the Supplier's risk and expense. 7. DELIVERY AND PERFORMANCE Delivery shall be strictly in accordance with the instructions detailed on the Order, including the date of delivery, and shall be at the risk of the Supplier. Delivery shall be made to the delivery address detailed on the Order during the following times unless agreed otherwise by the parties: -Sunday to Thursday - 8.00 a.m. to 4.00 p.m. (Delivery Location Time) in the delivery location in Saudi Arabia. For outside Saudi Arabia (Tunisia, United Arab Emirates, and Egypt) delivery times: -Monday to Friday - 8.00 a.m. to 4.00 p.m. (Delivery Location Time) in the delivery location. Each delivery of the Products should be accompanied by a delivery note that quotes the Order number. Where the Products are being delivered in installments, the delivery note must identify this along with the outstanding balance of Products remaining to be delivered. All temperature-sensitive Products must be clearly labeled to identify them as such and transported within the manufacturer's required storage temperature parameters. If for whatever reason delivery is not affected in accordance with the Order, then AcedrA may, without prejudice to any other right or remedy, wholly or partially terminate the Order without incurring liability to the Supplier. The Supplier shall meet any performance dates for the Services specified in the Order or that AcedrA notifies the Supplier. Title in the Products shall pass to AcedrA on the unloading of the Products at the delivery address detailed on the Order (or for international orders at the import terminal prior to customs clearance). Such passing of title shall not constitute acceptance of the Products. In the event of AcedrA being unable to accept deliveries, for whatever reason, AcedrA shall have the right to suspend, wholly or in part, deliveries under the Order. 8. INSPECTION AND REJECTION AcedrA shall have the right to inspect the Products when delivered and to review the Services. If the Products are not delivered on the delivery date identified in the Order, or if the Products and/or Services do not conform with the Order or do not comply with clause 5 of these conditions, then, without limiting any of its other rights or remedies, and whether it has accepted the Products or Services, AcedrA may: reject the Products or Services (in whole or in part) and return them to the Supplier at the Supplier's own risk and expense. Any Products or Services rejected shall be deemed as not having been delivered or performed; require the Supplier to repair or replace the rejected Products, to provide repeat performance of the Services, or to provide a full refund of the price of the rejected Products or Services; recover from the Supplier any costs incurred by AcedrA in obtaining substitute goods or services from a third party; and claim damages for any other costs, loss, or expenses incurred by AcedrA which are in any way attributable to the Supplier's failure to carry out its obligations. 9. PRICE Prices shall be as stated on the face of the Order and unless agreed otherwise shall be exclusive of Value Added Tax or similar tax and customs duties which if applicable shall be payable by AcedrA in addition to the Price at the rate in force under the applicable law. No alterations will be accepted unless by prior written agreement from AcedrA. Prices shall include costs of packaging, insurance, and carriage of the Products and include every cost and expense of the Supplier directly or indirectly incurred in connection with the performance of the Services. 10. INVOICES AND PAYMENT Invoices quoting the Order number, description, and quantity of Products delivered or Services provided shall be forwarded at the time of dispatch or after the completion of the Services to the relevant address as advised by AcedrA. Failure to detail any of the above information may result in a delay in payment by AcedrA. Unless otherwise stated in the Order, payment will normally be made in the month following the month in which the Products or Services in accordance with the Order, and a correct invoice, are received. 11. INDEMNITY In respect of the Order, the Supplier hereby agrees to indemnify and hold harmless AcedrA against all claims, damages, liabilities, and costs (including but not limited to any direct, indirect, or consequential losses, loss of profit, loss of reputation, and all interest, penalties and legal costs (calculated on a full indemnity basis) and all other reasonable professional costs and expenses) suffered or incurred by AcedrA resulting from: any damage, loss, death, or injury caused by an act, negligence, or omission arising out of or in connection with defects in Products or Deliverables, to the extent that the defects in the Products and Deliverables are attributable to the acts or omissions of the Supplier, its employees, agents or its subcontractors; any defect in or damage to the Products caused by or contributed to by the Supplier; any alleged or actual infringement of any Intellectual Property Rights in existence or pending at the date of the Order relating to the manufacture, supply, or use of the Products, or receipt, use, or supply of the Services and Deliverables; and any breach of Sanctions Laws. This clause shall survive the termination of an Order. 12. ASSIGNMENT The Supplier hereby agrees that no work in pursuance of the Order shall be assigned without the prior written consent of AcedrA. 13. CONFIDENTIALITY All confidential information associated with the Order, including confidential information concerning the business, affairs, customers, clients, or suppliers of the other party, shall be treated as strictly confidential between AcedrA and the Supplier. 14. PARTIAL INVALIDITY AND WAIVER Any provision of the Order subsequently found to be invalid shall not in any way affect the validity or enforceability of the remainder of the Order. Any failure by either party to enforce any provision of the Order shall not be construed as a waiver of that or any other provision. 15. NOTICES Any Notice or other communication entered into shall be in writing and addressed to the Supplier if notices are being given to the Supplier, or to the AcedrA entity named in the Order if notices are being given to AcedrA. 16. INTELLECTUAL PROPERTY All Intellectual Property Rights in Deliverables or arising out of or in connection with the Services (other than Intellectual Property Rights in any materials in the Deliverables that were owned by the Supplier prior to providing the Services ("Background IP") shall be owned by AcedrA unless agreed otherwise between the parties. The Supplier hereby assigns to AcedrA or shall procure the assignment to AcedrA of, all rights, title, and interest in the Deliverables (except to the Background IP) anywhere in the world. The Supplier hereby grants AcedrA a fully paid-up, non-exclusive, royalty-free, irrevocable, and perpetual license to use, modify and publish the Background IP to the extent it is incorporated in the Deliverables so that AcedrA may use the Deliverables in any way it wishes. AcedrA grants the Supplier a fully paid-up, non-exclusive, royalty-free non-transferable license to copy and modify any materials provided by AcedrA to the Supplier for the term of the Order for the purpose of providing the Services to AcedrA. 17. TERMINATION For Convenience- AcedrA shall have the right to terminate the Order in whole or part, at any time before delivery of the Products or completion of the Services, by serving on the Supplier written notice of termination. Upon receipt of such notice of termination, all terminated work shall be discontinued and AcedrA shall pay to the Supplier such sum as is fair and reasonable in respect of any direct loss sustained by the Supplier by reason solely of such termination and the Supplier agrees to accept such sum in full and final satisfaction of all claims arising out of such termination. In the event of termination of the Order, the Supplier shall use its best endeavors to mitigate the loss arising from such termination. In no case shall the amount payable by AcedrA for the terminated Services or Products exceed the price that would have been payable if the Services had been completed or the Products delivered. For Default- AcedrA shall notify the Supplier of any breach or default of these conditions. If the Supplier is unable to remedy such breach or default within a period of 30 days from the notice being given, then AcedrA reserves the right to terminate the Order in whole or part without incurring liability to the Supplier. For Insolvency- In the event that the Supplier becomes insolvent then AcedrA reserves the right to suspend or terminate the Order without incurring liability to the Supplier. Termination of an Order, however arising, shall not affect any of the parties rights and remedies that have accrued as at termination, including the right to claim damages in respect of any breach of these conditions which existed at or before the date of termination. 18. FORCE MAJEURE Neither party shall be in breach nor liable for delay in performing, or failure to perform, any of its obligations under these conditions if such delay or failure results from events, circumstances, or causes beyond its reasonable control. In such circumstances, the affected party shall be entitled to a reasonable extension of the time for performing such obligations. If the period of delay or non-performance continues for 2 weeks, the party not affected may terminate the Order immediately by giving written notice to the affected party. 19. DATA PRIVACY Where AcedrA processes your personal data in relation to the purchase of Products or Services under the Order we will comply with any applicable data protection legislation currently in force, including but not limited to governed by the Personal data protection law (Royal Decree No. (M/19) dated 1443/2/9 AH) , the Main Principles of Personal Information Protection, and the Main Principles and General Rules for Sharing Data issued by the Saudi Data and Artificial Intelligence Authority (SDAIA) and National Data Management Office (NDMO) . and any national implementing laws, regulations, and secondary legislation, as amended or updated from time to time and any successor legislation thereto. 20. ANTI-BRIBERY AND CORRUPTION Both AcedrA and the Supplier shall not, and shall procure that their respective directors and employees shall not, engage in any activity, practice, or conduct which would constitute an offense under any anti-bribery and anti-corruption laws, regulations, and codes in any jurisdiction, including but not limited to the Anti-Money Laundry of Saudi Arabia 20217 the UK Bribery Act 2010 and, where applicable, the US Foreign Corrupt Practices Act 1977 . 21. MODERN SLAVERY Each party shall and shall procure (where relevant) that all persons who are performing services or providing goods in connection with, or which will or may be used in performing or to support the performance of these conditions in any part of the world (collectively, its "Supply Chain") shall at all relevant times (a) comply with the provisions of Anti-Trafficking in Persons Law Royal Decree no. M/40, dated 21/7/1430H ; (b) not engage in any activity, practice, or conduct that would constitute an offense under the Anti-Trafficking and Modern Slavery Statement of AcedrA if such activity, practice, or conduct were carried out in the Kingdom of Saudi Arabia; and (c) take all reasonable steps to ensure that slavery and human trafficking are not taking place in its business or its Supply Chain. 22. SANCTIONS The Supplier and AcedrA acknowledge the existence of Sanctions Laws and shall ensure that they comply with all applicable Sanctions Laws to which either the Supplier or AcedrA is subject, including those of any jurisdiction where either the Supplier or AcedrA are located or incorporated. The Supplier and AcedrA shall not take any action or refrain from taking any action which would, or would in the reasonable opinion of the party subject to Sanctions Laws, cause the such party to breach such Sanctions Laws. The Supplier shall carry out appropriate due diligence with regard to any third party involved in the supply of the Products and Services. The Supplier shall ensure that it has no knowledge or reasonable cause to suspect that any activities relating to the Products or Services will, either directly or indirectly, involve any Sanctioned Person or will otherwise be in breach of Sanctions Laws. In the event of either party becoming a Sanctioned Person, the other party may terminate any Orders with immediate effect and without payment of compensation. 23. APPLICABLE LAW This Agreement and any Order shall be subject to and interpreted in accordance with the Laws of the Kingdom of Saudi Arabia and the Supplier hereby submits to the jurisdiction of the Saudi Courts. AcedrA T&Cs of Sales 1. DEFINITIONS In these terms and conditions (“T&Cs”), the following definitions shall apply: “Clinical Trial Products” means any products ordered from Us by You including without limitation pharmaceutical compounds and drugs, medical equipment, and medical supplies which are ordered by You for use strictly in connection with any clinical trial; “AcedrA Subsidiary” means any person that directly or indirectly is controlled by AcedrA Pharmaceutical Company LLC; “Contract” means any contract between You and Us incorporating these T&Cs for the sale of Products and/or the provision of the Services; “controlled by” means the power to direct or cause the direction of the management or policies of a person whether through the direct or indirect ownership of voting securities, by contract, resolution, regulation, or otherwise; “Field of Use” means the field of use and/or application for which You have engaged Us to perform the Services as stated in the Quotation where provided by Us and agreed by You or as otherwise agreed by Us and You in writing in an order placed by You and accepted by Us; “General Products” means any products ordered from Us by You including without limitation pharmaceutical compounds and drugs, medical equipment and medical supplies, and any ancillary Services required, but excluding the Clinical Trial Products; “Liability” means liability for any and all damages, claims, proceedings, actions, awards, expenses, costs, and any other losses and/or liabilities; "Order" means Your purchase order form, or Your written acceptance of Our Quotation, as the case may be; “Products” means General Products and Clinical Trial Products; “Quotation” means, where provided by Us, the form completed and signed by Us and You, confirming the price for the Products and Services and other variable details specific to your order; “Sanctions Laws” means any law, regulation, or wider measure applicable to either You or Us relating to the adoption, implementation, and enforcement of economic sanctions, export controls, and trade embargos; “Sanctioned Person” means any individual, entity, or body (i) specifically designated under Sanctions Laws, (ii) owned or controlled by any individual, entity, or body specifically designated or listed under Sanctions Laws, or (iii) acting for or on behalf of any individual, entity or body specifically designated or listed under Sanctions Laws; “Services” means without limitation the sourcing, procurement, and/or distribution of medicinal products, comparator drugs, other health products, medical supplies, and equipment, and managed access, clinical trials, pharmaceutical, clinical consultancy and advisory services, and/or work; “We, Us, Our” means AcedrA Pharmaceutical Company LLC or any AcedrA Subsidiary; “You, Your, Yourself” means the person, organization, or other business entity whose order for Products and/or Services is accepted by Us and to whom We subsequently supply the Products and/or Services. 2. BASIS OF CONTRACT AND QUOTATIONS 2.1 These T&Cs shall govern the agreement between You and Us to the exclusion of any other terms or conditions, including the exclusion of any terms or conditions which You may purport to apply under any purchase order, confirmation order, or similar document except that in the event of any conflict between these T&Cs and any signed agreement between You and Us the signed agreement shall take precedence. 2.2 No oral warranties or representations shall bind Us. No variation of these T&Cs shall be binding on Us unless agreed in writing between You and one of Our authorized representatives or contained in the relevant Quotation where provided by Us. Our employees, sub-contractors, and/or agents are not authorized to make any representations or warranties concerning the Products and/or Services unless confirmed by Us in writing. You acknowledge that You do not rely on any representation and/or warranty that has not been made in accordance with these T&Cs. 2.3 Quotations will not form part of the Contract unless accepted by signature by both You and Us within the time period specified on the Quotation ("Quotation Offer Period"). Quotations may be withdrawn by Us at any time during the Quotation Offer Period by oral or written notice. Notwithstanding this, We shall have the right to refuse to accept any orders placed for Products and/or Services under the Quotation. 2.4 All of these T&Cs shall apply to the supply of both Products and Services except where application to one or the other is specified. 3. Orders 3.1 The Contract between You and Us shall come into effect on Our acceptance of Your Order. No Order shall be deemed accepted by Us until confirmed in writing by Our authorized representatives. 3.2 You shall be responsible for the accuracy of an Order and for giving Us any information necessary to perform the Contract. 3.3 If You approve sample Products supplied by Us then You shall have no claim in respect of, nor any right to reject, the Products, provided those Products are of the same description, specification, quality, and fitness for purpose as the sample. 4. Delivery and performance 4.1 We shall deliver the Products to the location set out in the Order or such other location as the parties may agree ("Delivery Location"). We will use Our reasonable commercial endeavors to ensure delivery and/or performance on the dates specified in the Order, but dates for delivery and/or performance are estimates only and are not guaranteed. Time is not of the essence in relation to such dates and late delivery or perfor mance shall not entitle You to cancel the Order. They are also subject to any matter beyond Our reasonable control. 4.2 Delivery shall be deemed to occur: 4.2.1 where Products are delivered by Us to You: at the time when the Products arrive at the Delivery Location; or 4.2.2 where Products are collected by You: on collection from the designated collection address and in any event, no later than 3 Working Days after You have been notified that the Products are available for collection in accordance with clause 4.9. 4.3 Where we require the return of any packaging material, You shall make any such packaging materials availa ble for collection at such times as We shall reasonably request. Returns of packaging materials shall be at Our expense. 4.4 If Products are to be delivered in installments , each delivery shall constitute a separate and distinct contract. Failure by Us to deliver, or a claim by You regarding, any installment under a separate and distinct contract shall not entitle You to repudiate and/or terminate the Contract as a whole or any other separate and distinct contract or Order. 4.5 Where Services are to be performed in stages, each stage shall constitute a separate and distinct contract. Failure by Us to deliver or any claim by You in respect of, any stage under a separate and distinct contract shall not entitle You to repudiate and/or terminate the Contract as a whole or any other separate and distinct contract or Order. 4.6 We shall not be required to fulfill Orders for Products and/or Services in the sequence in which they are placed. 4.7 You shall procure during normal working hours that We have free rights of access to the Delivery Location or the relevant location to perform the Services. You shall be responsible at Your own cost for all arrangements to unload the Products when delivered to You. Unless otherwise agreed in writing, delivery of Products and performance of Services will be made between 0800 hours and 1700 hours, Sunday to Thursday, excluding public holidays in Saudi Arabia and the country of the Delivery Location (“Working Days”). 4.8 If You fail or refuse to t ake delivery of any Products and/or to allow performance of the Services then We shall be entitled to withhold delivery and/or performance of those Products and/or Services and to treat the Contract for that particular Order as repudiated by You. If any delay to take delivery of any Products is caused by You, We may store the Products for at least 7 Working Days in accordance with clause 4.9, and charge You for all related costs and expenses (including insurance). 4.9 If We agree that the Products are to be collected from Us by You then You shall collect the Products within 3 Working Days of being notified that the Products are ready for collection. If the Products are not collected by You within this tim e We may store the Products at Your expense and risk until collection. 4.10 If after 7 Working Days, you do not rectify the failure or refusal to take delivery of Products or to allow performance of the Services under clause 4.9, or You do not collect the Products from Us within the time period specified in clause 4.9, We may in Our discretion sell or otherwise dispose of part or all of the Products and will no longer make the Services available to you. 4.11 Where the quantity of Products delivered is not in accordance with the Order, You must notify Us within 3 working days of delivery or within 1 day of delivery in relation to cell therapy or gene therapy Products. We will remedy any shortfall in delivery where We consider an error in the order has occurred solely by Us. 4.12 If We accept that any Services we have supplied have not been supplied in accordance with the Contract We will perform such Services again so that they are in accordance with the Contract. 5. Damaged and Defective Products 5.1 Any Products which are alleged to be defective or damaged must be notified to Us within 5 Working Days of delivery or collection, or within 1 day of delivery or collection in relation to cell therapy or gene therapy Products, with a written report of the alleged defect or damage, and where reasonable and if requested by Us be returned to Us within 10 Working Days of the date of delivery or collection in their original boxes and packaging for inspection. We will alert the Product manufacturer as quickly as reasonably possible and: 5.1.1. if the Products are confirmed as being defective then a credit for the price of the defective Products or replacement will only be issued by Us as authorized by the manufacturer concerned, and whichever option is provided is at the discretion of the manufacturer and/or Us; and 5.1.2. if the Products are confirmed as being damaged then either a refund or credit will be offered to You at Our discretion. 5.2 We will not accept Product returns except solely where agreed by Us in accordance with these T&Cs or in relation to a Product recall. 5.3 If, after the time periods referred to in clause 5.1 have passed and You have not raised any allegations of defective or damaged Products, You are deemed to have accepted the Products. 6. Postponement and Cancellatio n 6.1 We may comply with reasonable requests by You for postponement of delivery and/or performance but shall be under no obligation to do so. Where delivery and/or performance is postponed at Your request and We have agreed to that postponement, then We may require that You pay all Our costs and expenses incurred as a result including, but not limited to, reasonable charges for storage, transportation, and insurance. In addition, You shall be obliged to pay for the Products and/or Services in accordance with clause 7 as if delivery and/or performance had not been postponed. 6.2 If You wish to cancel an Order which has been accepted by Us, you must notify us immediately. Except where cancellation occurs in accordance with clause 8.1, at Our discretion, we may agree to the cancellation of the Order and termination of the relevant Contract. Our agreement to terminate the Contract for that Order will only be effective upon one of Our authorized representatives agreeing to it in writing. Notwithstanding our acceptance of a cancellation, We may require in Our discretion that You indemnify Us in full against all loss (including loss of profit), costs (including the cost of all labor and materials used), damages, charges, and expenses incurred by Us as a result of cancellation. 6.3 If you purport to cancel an Order without our consent an d/or refuse to accept delivery of ordered Products and/or the performance of any ordered Services You will: 6.3.1 have no further recourse against Us under the Contract; and 6.3.2 indemnify and keep Us indemnified against any and all lost profits, costs (including increased administration costs and legal costs on a full indemnity basis), expenses, damages, and any other loss and/or Liability suffered by Us as a result. 7. Price, Payment, and Credit Limit 7.1 The price of the Products and/or the Services shall be as specified in the Quotation or where no Quotation is signed by Us and You, as otherwise specified in writing by Our authorized representatives and confirmed in a written order. Except as otherwise stated, prices are exclusive of any transport, packaging, and/or insurance costs and are exclusive of any applicable taxes and duties for which You shall additionally be liable. 7.2 Where any taxable supply for Value Added Tax or similar tax purposes is made under the Contract by Us to You, You shall, on receipt of an invoice from Us, pay to Us such additional amounts in respect of such Value Added Tax or similar tax as are chargeable on the supply of the Services or Products at the same time as payment is due for the supply of the Services or Products. 7.3 We may increase Our prices where an increase in costs, expenses, and/or materials is suffered by Us (including, without limitation, any factor outside of Our control such as any foreign exchange fluctuation, currency regulation, and alteration of duties). You will be informed in advance and in writing by Us of any price increases for the Products and/or the Services as soon as practicable after we become aware of any changes. You may cancel without Liability any Contract in relation to which the price is to be increased, provided that the notice of cancellation is received by Us before the change becomes effective. 7.4 If Y ou do not cancel the Contract for the provision of the Products and/or Services before the price increase becomes effective then the price increase shall take effect for the Products and/or Services ordered by You. 7.5 Unless otherwise agreed in writing by Us or specified in the Quotation: 7.5.1 Our terms of payment are 30 days from the date of invoice; 7.5. 2 time for payment shall be of the essence; 7.5.3 all invoices issued on a pro-forma basis are due for immediate payment; and 7.5.4 payment of a n invoice shall be in full and in cleared funds to a bank account nominated in writing by Us. 7.6 If You fail to make any payment in full on the due date then, without prejudice to any other right or remedy available, We may charge You any reasonable additional administration costs and/or interest (both before and after judgment) on the amount unpaid at the rate of 4% per annum above the base rate from time to time of Our bank. 7.7 We may invoice each delivery of Products and/or stage of the Services separately. We will render an invoice to You at any time and/or at any stage during the performance of the Contract. 7.8 You shall pay all sums due to Us without any set-off, deduction, counterclaim, and/or any other withholding. Payment shall not be deemed to be made until We have received either cash or cleared funds in respect of the full amount outstanding. 7.9 If payment in full is not made to Us when due then We may withhold or suspend future or current deliveries of the Products and/or performance of the Services and delivery and/or performance under any other agreement with You and/or cancel the Contract. 7.10 If any Services are canceled, the Contract is terminated, or delivery and/or performance is suspended before the completion of the Services, We are entitled to be paid on a quantum meruit basis for that part of the Services performed. We may invoice You accordingly and such monies shall be due for payment in accordance with clause 7.5. 7.11 We may set a reasonable credit limit for You. We may refuse to accept orders for Products and/or Services and/or suspend or withhold delivery of Products and/or Services if such Products and/or Services would result in You exceeding or you have exceeded Your credit limit. 8. Specification, Intellectual Property Rights, and Confidentiality 8.1 Specifications supplied by Us to You shall only be approximate unless stated in the Quotation or otherwise agreed in writing. If there is an error in the specification made by Us in the Quotation or as otherwise agreed in writing by Us, where that error is material and it has been relied upon by You, You may cancel that part of the Contract only which is affected by the error without Liability due to the cancellation in respect of that part canceled. 8.2 The quantity, quality, description, and/or specification for the Products and/or the Services shall be that set out in Your Order. You are responsible for checking the Order and satisfying Yourself that any specification given is accurate and adequate for the Products and/or Services. 8.3 We shall have no liability for errors in any specification or details supplied by You. We will use all reasonable endeavors to provide final products to the same specification as proofs or samples, however, no guarantee is expressed or implied that the entire consignment of Products will have the same specification as the sample. 8.4 We warrant that, where Products are supplied by description and not sample, on delivery, the Products will comply with their description in the Order in all material respects. We warrant that the Services will be provided using reasonable care and skill. 8.5 You shall not make any modification to the Products or their packaging, nor alter, remove, or tamper with any trademarks used on or in relation to the Products and/or Services. All intellectual property rights (including without limitation all patents, copyright, design rights (whether registered or unregistered), trademarks (whether registered or unregistered) skill and/or know-how, and other similar rights, whether existing now and/or in the future, wherever existing in the world together with the right to apply for protection of the same): 8.5.1 in the Products and/or their packaging shall be owned by Us or the relevant manufacturer (as appropriate) absolutely; 8.5.2 arising from the Services shall be owned by Us absolutely (excluding materials provided by You to Us in order to perform the Services). 8.6 You will at Our cost and request, do all acts and/or things and execute all documents and/or deeds to give effect to clause 8.5 above and/or to assist Us in the application, registration, renewal, and/or protection of such intellectual property rights. 8.7 We reserve absolutely all rights to be identified as the authors of any works arising and/or generated from the Services in accordance Saudi Authority for Intellectual Property . We may utilize for the benefit of Our other customers any skill and/or know-how developed and/or acquired in the performance of the Services. 8.8 We grant to You a non-exclusive royalty-free license to use within the Field of Use all intellectual property rights owned by Us which arise solely from the Services except that We shall be entitled to use such intellectual property rights inside and outside of the Field of Use for ourselves and for con ducting other research and/or projects for Our other customers. All rights and licenses not specifically and expressly granted to and conferred upon You by the Contract are for all purposes reserved to Us. 8.9 We may terminate the license granted under clause 8.8 at any time with immediate effect upon notice if any of the events in clause 10.2 occur in relation to You and/or if You use, attempt to use, and/or We reasonably suspect that you intend to use the intellectual property rights (specified in clause 8.5) arising from the Services otherwise than in accordance with the Contract. 8.10 You grant to Us a fully paid-up, non-exclusive, royalty-free license to copy and modify any materials provided by You to Us for the term of the Contract for the purpose of providing the Services. 8.11 Each party undertakes that it shall not at any time during the Contract, and for a period of five years after termination or expiry of the Contract, disclose to any person any confidential information concerning the business, affairs, customers, clients or suppliers of the other party, except as permitted by clause 8.12. 8.12 Each party may disclose the other party's confidential information: 8.12.1 to its employees, officers, representatives, contractors or subcontracts, or advisers who need to know such information for the purposes of exercising the party's rights or carrying out its obligations under or in connection with the Contract. Each party shall ensure that its employees, officers, representatives, or advisers to whom it discloses the other party's confidential information comply with this Clause 8; and 8.12.2 as may be required by law, a court of competent jurisdiction, or any governmental or regulatory authority. 8.13 No party shall use any other party's confidential information for any purpose other than to exercise its rights and perform its obligations under or in connection with the Contract. 9. Property and Risk 9.1 Risk in the General Products under an Order shall pass to You at the time of delivery as identified in clause 4.2. 9.2 We shall retain the title of the General Products under an Order until We have received payment in full in cash or cleared funds of all sums due and/or owing in relation to those General Products. 9.3 Until We have received full payment for General Products supplied to You, You shall store the General Products separately from any products or goods belonging to You or any third party and the General Products must be clearly identified as being Our property. You agree that Our employees and/or agents shall be entitled to enter Your premises to check compliance with this clause, and You agree to provide them with access. You shall properly store and protect the General Products and keep the General Products insured for the price at which the General Products were sold to You against all insurable risks and shall hold any proceeds of such policy of insurance relating to the General Products on trust for Us and account to Us for any proceeds of such policy of insurance relating to the General Products upon receipt of the same. Any monies received from You by Us in accordance with this clause shall not discharge Your liability to pay the price for the General Products plus interest accrued in accordance with clause 7.6 but shall be set off against such liability. 9.4 In the event that there is no payment due for the General Products provided by Us to You, the title shall pass to You at the time of delivery as defined in clause 4.2. 9.5 Title to the Clinical Trial Products and liability for risk of loss or damage shall pass from Us to You immediately after We have purchased and ourselves acquired title to the relevant Clinical Trial Products. You shall be responsible for arranging insurance in respect of the Clinical Trial Products immediately after We have purchased the relevant Clinical Trial Products. We shall only be liable for any damage caused to the Clinical Trial Products, on a contractual or non-contractual basis, to the extent that such damage is caused by Our wilful misconduct or recklessness. 10. Termination and Default 10.1 Without affecting any other right or remedy available to it, either party may terminate a Contract by giving the other party not less than 12 months' written notice. 10.2 If You:- 10.2.1 fail to make payment to Us when due; 10.2.2 breach the terms of the Contract and, if capable of remedy, have not remedied the breach within 10 Working Days of receiving notice requiring it to be remedied; 10.2.3 persistently breach any one or more terms of the Contract; 10.2.4 pledge or charge any Products which remain Our property, or cease or threaten to cease to carry on business, or propose to compound with Your creditors, apply for an interim order under Section 252 Insolvency Act 1986 or have a Bankruptcy Petition presented against You, enter into voluntary or compulsory liquidation, have a receiver, administrator or administrative receiver appointed over all or any of Your assets, or take or suffer any similar action in any jurisdiction; 10.2.5 appear from Your credit rating to be financially unable to meet Your obligations under the contract; and/or 10.2.6 appear reasonably to Us to be about to suffer any of the events described in 10.2.4 and 10.2.5; then We shall have the right, without prejudice to any other remedies, to exercise any or all of the rights set out in clause 10.3. 10.3 If any of the events in clause 10.2 occur in relation to You then:- 10.3.1 We may enter, without prior notice, and You shall give us access to, any of Your premises (or premises of third parties, of which You shall procure that We are given access to) where Products owned by Us may be and repossess and dispose of or sell any Products found which are owned by Us so as to discharge any sums due to Us under this Contract or any other agreement with You; 10.3.2 We may require You not to re-sell or part with the possession of any Products owned by Us until You have paid in full all sums due to Us under the Contract or any other agreement; 10.3.3 We may withhold delivery of any undelivered Products and/or performance of any Services and stop any Products in transit and/or cease any Services in progress; 10.3.4 We may cancel, terminate and/or suspend without Liability to You any agreement with You; and/or 10.3.5 All monies owed by You to Us shall become due and payable immediately. 10.4 Additionally, if any of the events in clauses 10.2.4 – 10.2.6 occurs in relation to You, We shall have a lien over all property or goods belonging to You in Our possession in respect of all sums due from You to Us, and upon the termination of the Contract if monies due to Us from You have not been paid within 7 Working Days of termination We may sell any property or goods over which We have a lien (and You agree that We may give good title for such property and/or goods) and shall apply the proceeds of sale firstly in discharging any costs or expenses of sale, secondly in repaying any interest or expenses owed by You to Us, thirdly in payment of any principal sums owed to Us and fourthly We shall account to You for the remainder (if any). 11. Limitations On Liability 11.1 We shall have no Liability: 11.1.1 for any loss arising from the use of the Product by an end user unless such Liability can be demonstrated to have arisen as a direct result of our wilful misconduct or recklessness in handling the supply of the Product; 11.1.2 for any defect in the Products caused or contributed to as a result of the Products being used for display or demonstration purposes or being handled by You or Your customers; 11.1.3 for defective Products and/or Services where (i) the defect has been caused or contributed to by You to the extent so contributed; (ii) You continue to use the Products or Services after giving notice of defect under clause 5; (iii) the defect arises because You failed to follow Our oral or written instructions as to the storage, installation, commissioning, use or maintenance of the Products; (iv) the defect arises as a result of Our following instructions from You to alter or amend the Products; (v) You alter or repair the Products without Our consent; or (vi) the defect arises as a result of wilful damage or negligence by You; 11.1.4 to You for breach of warranty where the Products differ from their description as a result of changes made to ensure they comply with applicable statutory or regulatory standards; 11.1.5 to You if the price for the Products and/or the Services has not been paid in full by the due date for payment; 11.1.6 to You for defective or damaged Products and/or Services and incorrect quantity of Products delivered unless the event is notified to Us within the appropriate time limit set out in the Contract; 11.1.7 to You for Products not despatched or Products lost in transit unless the event is notified to Us within 3 Working Days of such event occurring; 11.1.8 for damage, loss, liability, claims, costs, or expenses caused or contributed to by the continued use of defective Products and/or Services after a defect has become apparent or suspected or should reasonably have become apparent to You; 11.1.9 to You to the extent that You are covered by any insurance policy and You shall ensure that Your insurers waive any and all rights of subrogation they have against Us; 11.1.10 for any consequential losses, including but not limited to: loss of profits and/or damage to goodwill; economic and/or other similar losses; special damages and indirect losses; and/or business interruption, loss of business, contracts, opportunity, and/or production. 11.2 You shall: 11.2.1 give Us an opportunity to remedy any matter for which We are liable before You incur any costs and/or expenses in remedying the matter Yourself; 11.2.2 produce to Us written evidence of any claims you allege that We are liable together with written details of how the loss was caused and the steps taken by You to mitigate the loss; 11 .2.3 be under a duty to mitigate any loss, damage, costs, or expenses that You may suffer (including by maintaining an adequate stock of Products). 11.3 Our total Liability to You shall not exceed: 11.3.1 in respect of any claims relating to Clinical Trials Products, an amount equal to 10 (ten) percent of the value of the Clinical Trials Products to which the relevant claim relates; or 11.3.2 in respect of any other claims, SAR 1,000,000 (1 million Saudi Riyals). 11.4 Each of the limitations and/or exclusions on liability in the Contract shall be deemed to be applicable for each of: 11.4.1 Liability for breach of contract; 11.4.2 Liability in tort (including negligence); 11.4.3 Liability for breach of statutory duty; 11.4.4 Liability for breach of Saudi Trade Law, except clause 11.3 above which shall apply once only in respect of all the said types of Liability; and 11.4.5 All warranties, terms, conditions, and duties implied by law relating to fitness, quality, or adequacy are excluded to the fullest extent permitted by law. 11.5 Nothing in the Contract shall exclude or limit Our Liability for death or personal injury due to Our negligence or any Liability which is due to Our fraud or fraudulent misrepresentation or any other liability which it is not permitted to exclude or limit as a matter of law. 11.6 You will indemnify and keep indemnified Us against any and a ll losses, proceedings, lost profits, damages, awards, expenses, costs (including increased administration costs and legal costs on a full indemnity basis), claims, actions and any other losses and/or liabilities suffered by Us and arising directly or indirectly from or due to: 11.6.1 any loss arising from the use of the Product by an end user unless such Liability can be demonstrated to have arisen as a direct result of Our actions in handling the supply of the Product; 11.6.2 an y breach of contract, any tortious act and/or omission, and/or any breach of statutory duty by You; 11.6.3 any breach by You of Sanctions Laws; and/or 11.6.4 Our use of specifications, details, and/or stipulations supplied by You. 12. Data Privacy 12.1 Where We process your personal data in relation to the purchase of Products or Services under the Contract We will comply with any applicable data protection legislation currently in force, including but not limited to governed by the Personal data protection law (Royal Decree No. (M/19) dated 1443/2/9 AH) , the Main Principles of Personal Information Protection, and the Main Principles and General Rules for Sharing Data issued by the Saudi Data and Artificial Intelligence Authority (SDAIA) and National Data Management Office (NDMO) . any national implementing laws, regulations, and secondary legislation, as amended or updated from time to time any successor legislation thereto. 13. Anti-Bribery and Corruption 13.1 Both We and You shall not, and shall procure that Our and Your respective directors, employees, agents, representatives, contractors, or sub-contractors shall not, engage in any activity, practice, or conduct which would constitute an offense under any anti-bribery and anti-corruption laws, regulations and codes in any jurisdiction, including but not limited to the Anti-Money Laundry of Saudi Arabia 20217 and the UK Bribery Act 2010 and, where applicable, the US Foreign Corrupt Practices Act 1977 . 14. Modern Slavery 14.1 Both parties shall and shall procure that its directors and employees shall at all relevant times (a) comply (a) comply with the provisions of Anti-Trafficking in Persons Law Royal Decree no. M/40, dated 21/7/1430H ; (b) not engage in any activity, practice, or conduct that would constitute an offense under the Anti-Trafficking and Modern Slavery Statement of AcedrA if such activity, practice, or conduct were carried out in the Kingdom of Saudi Arabia; and (c) take all reasonable steps to ensure that slavery and human trafficking are not taking place in its business or its Supply Chain. 15. Sanc tions 15.1 Both We and You acknowledge the existence of Sanctions Laws. We shall ensure that We comply with all applicable Sanctions Laws to which We are subject, including those of any jurisdiction where We are located or incorporated. You shall ensure that You comply with all applicable Sanctions Laws to which You are subject, including those of any jurisdiction where You are located or incorporated. 15.2 Both We and You shall not take any action or refrain from taking any action which would, or would in the reasonable opinion of the party subject to Sanctions Laws, cause the such party to breach such Sanctions Laws. 15.3 You shall carry out appropriate due diligence with regard to any third party to whom the Products or Services are re-sold, re-supplied, re-exported, or re-transferred. You shall ensure that You have no knowledge or reasonable cause to suspect that any activities related to the Products or Services will, either directly or indirectly, involve any Sanctioned Person or will otherwise be in breach of Sanctions Laws. 15.4 In the event of Us or You becoming a Sanctioned Person, the other party may terminate any Contracts with immediate effect and without payment of compensation. 16. General 16.1 No waiver by Us of any breach of the Contract shall be considered as a waiver of any subsequent breach of the same provision or any other provision. If any provision of the Contract is held by any competent authority to be invalid or unenforceable in whole or in part the validity of the other provisions of the Contract and the remainder of the affected provision shall be unaffected and shall remain in full force and effect. 16.2 Either party shall have no Liability to the other for any delay in performance of the Contract (other than in relation to payment) where such delay is due to events outside the affected party's reasonable control including without limitation to acts of Allah, war, flood, fire, labor disputes, subcontractor delays, strikes, lock-outs, riots, civil commotion, malicious damage, explosion, governmental actions, and any other similar events. If a party is affected by such events then the time for performance shall be extended for a period equal to the period that such events delayed performance. 16.3 You shall not assign Your interest in the Contract (or any part) without Our written consent. We may assign, transfer, or sub-contract all or any part of our obligations and/or interest in the Contract to any third party without notice. 16.4 All third-party rights are excluded and no third party shall have any right to enforce the Contract. Any right of a third party to enforce the Contract may be varied and/or extinguished by agreement between the parties to the Contract without the consent of the such third party. 16.5 The Contract is governed by and interpreted in accordance with the Kingdom of Saudi Arabia law and the parties agree to submit to the exclusive jurisdiction of the Saudi Courts. AcedrA T&Cs of Purchases Consumer Information Obligations Our main activity within AcedrA relates to the supply of packaged goods/goods that are packaged to the final user of the packaging, someone who will discard that packaging. This could be postal packaging, such as if we sell products to a distributor who removes our packaging and repackages the products, or it could be selling a packaging product to the final end user. To this end, we are required under the Consumer information obligations to give our customers information about: return, collection, and recovery systems they can use their role in reusing, recovering, and recycling packaging and packaging waste what do recovery and recycling symbols on the packaging mean how to get copies of waste strategy guidance In order to achieve this AcedrA has provided links below to the relevant government websites that provide this information. the Saudi Investment Recycling Company (SIRC) AcedrA Tax Strategy BACKGROUND AcedrA is a trusted Regional and Local Leader in the highly regulated pharmaceutical industry dedicated to enabling quicker and broader access to critical medicines around the world for patients with unmet needs. Our mission is to deliver the right medicine to the right patient at the right time. AcedrA provides innovative pre and post-launch niche services to pharmaceutical and Biotechnology companies to help them accelerate development and access to their medicines and is a ’ go-to place for healthcare professionals to gain access to these critical medicines in licensed and unlicensed markets. Supplying customers in over 8 countries and shipping over 3 million units annually our business activities incur a substantial amount and variety of taxes, including corporate income tax, business rates, stamp taxes, and in the Kingdon of Saudi Arabia, employer’s national insurance. In addition, we collect and pay employment taxes and indirect taxes such as VAT. AcedrA’s core values, outlined in “Our DNA”, encourage honesty and transparency, and we pride ourselves on our integrity and openness and empower our staff to challenge management if these principles are not adhered to. In accordance with the Saudi Finance Laws for Companies , this strategy has been published online and applies to AcedrA and all its subsidiaries and applies from the date of publication until it is superseded. OUR APPROACH TO RISK MANAGEMENT AND GOVERNANCE AcedrA identifies and manages risks and opportunities, including tax risk, that may affect the achievement of its strategic objectives and business plans, its shareholder value, and its reputation, through its risk management process. The Board has responsibility for establishing and maintaining the internal control systems which are monitored to ensure compliance with laws and regulations. The Chief Financial Officer provides updates to the Board on key risks and controls within the company. Tax risk arises due to the complexity of tax legislation and potential differences in interpretation, and in relation to AcedrA’s business operating model. AcedrA has established policies and procedures to ensure the integrity of its tax filings and other tax compliance obligations in the Kingdom of Saudi Arabia and worldwide, and our processes are subject to the same level of internal controls, review, and external audit as the rest of the business. Tax risk is viewed no differently than any other business risk encountered. For routine and established tax compliance procedures, we have a very low tolerance for risk and aim for a high standard of accuracy and compliance with reporting procedures and deadlines. AcedrA has appropriately qualified finance resources who receive the necessary guidance and training to keep up to date with new tax legislation and are supported to seek additional professional tax advice where appropriate. The finance resource maintains regular lines of communication with the commercial and functional teams across the business to ensure the tax effects of business developments are identified and understood. OUR ATTITUDE TO TAX PLANNING We have a responsibility to our shareholders to ensure our operations and financial activities are conducted in a tax-efficient manner. We aim to structure our operations and finances in a tax-efficient manner which may include tax planning. This tax planning is seeking to maximize shareholders' value by utilizing available tax reliefs, incentives, and exemptions where appropriate and ensuring that any arrangements are in the spirit of and comply with the tax legislation in question. Professional advice is sought on a transactional basis, with the depth of that advice driven by our assessment of the risk presented and the level of complexity involved. LEVEL OF TAX RISK WE ARE PREPARED TO ACCEPT AcedrA’s approach to tax planning is to ensure compliance with tax laws and regulations, both in the Kingdom of Saudi Arabia and worldwide, and to ensure that we identify and mitigate tax risks. Tax risk is assessed for each significant transaction. We have no defined limit of the risk we are prepared to accept, we will assess, manage and mitigate the tax risk to an acceptable level on a case-by-case basis. We maintain relationships with reputable external tax advisors that allow us to seek expert advice on specialist areas of tax, and in situations where the tax law is unclear or where internal expertise is insufficient. OUR APPROACH TO DEALING WITH TAX AUTHORITIES AcedrA seeks to ensure its engagement with the Saudi Zakat, Tax and Customs Authority (and other tax authorities in other jurisdictions) is professional, open and honest, and undertaken in the spirit of cooperation. Our aim is to work collaboratively and proactively with tax authorities to resolve matters arising which may include areas such as where legislation or guidance is unclear and there is a significant tax impact. We aim to respond to requests for information in a timely manner and we submit all returns on time. Where appropriate the company seeks advance clearance from tax authorities on the proposed tax treatment of transactions. Reviewed and Updated on 20th of March 2023 AcedrA Board of Directors AcedrA CEO Department AcedrA Compliance Department AcedrA Finance Department AcedrA Operations Department Acedra Commercial Department Hotline: (Toll-Free) 8001240411 legal.affairs@acedrarx.com

404 Looks like this page no longer exists. Back to Homepage

Contactez-Nous N'hésitez pas à nous contacter. Notre équipe d'experts expérimentés se fera un plaisir de vous aider à trouver la meilleure solution pour vos besoins. Qu'il s'agisse d'un médicament spécialisé, d'un équipement, d'un appareil, d'informations médicales ou de quelque chose de plus courant, nous pouvons vous aider. Contactez-nous aujourd'hui et faites-nous savoir comment nous pouvons vous aider! Siège social et centre logistique Nous contacter Contact Forme générale ou par thème Emplacements Cartes et informations Si vous souhaitez nous faire part de vos commentaires sur ce site Web, veuillez Cliquer ici Internships Locations

Licence Demander maintenant Prestations de service Ceci est votre page de services. C'est une excellente occasion de fournir des informations sur les services que vous fournissez. Double-cliquez sur la zone de texte pour commencer à modifier votre contenu et assurez-vous d'ajouter tous les détails pertinents que vous souhaitez partager avec les visiteurs du site. Contact Us Licence Next Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour modifier le contenu et assurez-vous d'ajouter toute information pertinente que vous souhaitez partager avec vos visiteurs. Programmes gérés et à accès anticipé Next Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour modifier le contenu et assurez-vous d'ajouter toute information pertinente que vous souhaitez partager avec vos visiteurs. Affaires réglementaires et médicales Next Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour modifier le contenu et assurez-vous d'ajouter toute information pertinente que vous souhaitez partager avec vos visiteurs. Distribution et chaîne d'approvisionnement Next Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour modifier le contenu et assurez-vous d'ajouter toute information pertinente que vous souhaitez partager avec vos visiteurs. Gestion complète de l'agence Next Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour modifier le contenu et assurez-vous d'ajouter toute information pertinente que vous souhaitez partager avec vos visiteurs. Conseil & Consultance Next Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour modifier le contenu et assurez-vous d'ajouter toute information pertinente que vous souhaitez partager avec vos visiteurs. Services personnalisés Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer à modifier le contenu. business.development@acedrarx.com Message from the CEO Licensing

Make your career soar to new heights with AcedrA! Our vacancies have an array of opportunities for you to progress and become successful. With our job roles, you can unlock the potential in yourself and take your career to the next level. Start Lean A Free Webinar on How to Unleash Your Inner Entrepreneur. Save My Spot Presented by Tamala Francis, Founder & CEO at Francis & Co. Introduce the webinar hosts by highlighting their career background or professional history. Just click “Edit Text” or double click the Text Box to add your own content. Save My Spot In this webinar we will cover Digital Marketing Funnel You can easily add your own content to this paragraph. Click on “Edit Text” or double click the Text Box to make it your own. Your Social Media Presence You can easily add your own content to this paragraph. Click on “Edit Text” or double click the Text Box to make it your own. Practical Branding Strategies You can easily add your own content to this paragraph. Click on “Edit Text” or double click the Text Box to make it your own. Check our Job Vacancies I want to join the webinar, Sign me up! First Name Last Name Email Message Submit Thanks for submitting! A Journey to Success Internships

Responsabilité sociale des entreprises Socialement responsable à chaque étape AcedrA Corporate Social Responsibility implique d'assumer la responsabilité de l'impact de nos actions sur l'environnement et les communautés au sein desquelles nous opérons. Cela inclut les impacts liés à la durabilité sociale, économique et environnementale. Une bonne gouvernance d'entreprise et agir conformément aux objectifs de développement durable sont des éléments essentiels de la responsabilité sociale des entreprises d'AcedrA. AcedrA depuis sa création s'est rendu compte que les efforts d'investissement dans ce domaine peuvent non seulement se traduire par un sentiment public positif, mais également par le succès à long terme de nos initiatives commerciales. AcedrA Corporate Social Responsibility (CSR) est une forme d'autorégulation par les entreprises, par laquelle elles surveillent et s'assurent que leur impact sur l'environnement et la société est positif. Pour ce faire, AcedrA a impliqué l'examen de tous les aspects des opérations d'une entreprise, y compris la conformité environnementale, sociale et de gouvernance avec les objectifs de développement durable. Les activités de RSE vont de l'approvisionnement en matériaux produits de manière éthique à l'investissement dans les économies locales ou à la défense des communautés marginalisées. En s'engageant dans des responsabilités significatives qui profitent aux parties prenantes, AcedrA a le potentiel de provoquer des changements positifs à l'échelle locale et régionale vers une durabilité à long terme. Les objectifs de développement durable Nous sommes heureux de faire partie du Pacte Mondial des Nations Unies En savoir plus sur le Pacte Mondial des Nations Unies Le Pacte mondial des Nations Unies est le plus grand au mondela durabilité d'entreprise initiative avec +13 000 entreprises participantes et autres parties prenantes dans plus de +170 pays avec deux objectifs : « Intégrer les dix principes dans les activités commerciales à travers le monde » et « Catalyser les actions à l'appui des objectifs plus larges de l'ONU, tels que comme le Objectifs de développement du millénaire (OMD) et Objectifs de développement durable (ODD) ". Pour aller de l'avant, le Pacte mondial des Nations Unies et ses signataires sont profondément investis et enthousiastes à l'idée de soutenir le travail vers les ODD. En savoir plus sur les objectifs de développement durable Net Zero Net zero is a sustainability target that seeks to balance any greenhouse gas emissions with removals or offsets. It involves reducing emissions as much as possible and investing in activities that will absorb an equivalent amount of carbon dioxide or other greenhouse gases from the atmosphere. This helps to ensure that the total impact of human activity on our environment is close to zero. Net zero initiatives are becoming increasingly popular and are seen as a way for businesses to demonstrate their commitment to sustainability. By setting net zero targets, businesses can reduce their carbon footprint and contribute to the global effort of achieving climate neutrality. In addition, such commitments can also help businesses lower costs associated with energy use and bolster their reputation in the marketplace. As countries, businesses, and individuals continue to strive for greater sustainability, Net Zero targets are becoming more commonplace. It is essential that we all take action toward this goal in order to ensure a sustainable future. Learn More We are gladly part of Science Based Targets Race To Zero We Mean Business Coalition Race To Zero Support Patients' Community AcedrA is committed to improving the quality of life in the Middle East and North African region by providing support through patient advocacy groups. We are dedicated to increasing awareness regarding rare diseases and special conditions, as well as connecting patients with medical professionals who can provide the best care for their needs. Our goal is to ensure that all patients receive the treatment they need and have access to the medical support they require. We are passionate about making a difference in people's lives, and we strive to provide our community with the resources needed to lead healthy and fulfilling lives. Discover our Capabilities in Medical Support Support for Scientific Community AcedrA is also strongly committed to education and research, believing that advanced knowledge of rare diseases can open up more treatment options for those affected. We believe that by educating the public about these diseases, more people will be able to make informed decisions about their health and seek the help they need. Our research initiatives are designed to gather data on rare diseases and special conditions in order to develop better strategies for diagnosis, treatment, and management of these conditions. Discover our Capabilities in Medical Support Support for Physically Challenged Persons AcedrA is committed to leveling the playing field and offering everyone the same chances in life, no matter what their physical disability may be. We believe that all individuals have a right to succeed and should be given the chance to do so. We strive to provide physically challenged persons with the ability to work in a safe and supportive environment ensuring that every person has equal access to opportunities regardless of their physical limitations. Discover LIFE@AcedrA We are compliant with "MOWAAMAH " M owaamah is part of the Ministry of Human Resources & Social Development's programs, launched in the implementation of the Strategy for the Rights of Persons with Disabilities. To provide a suitable work environment for persons with disabilities, according to specific criteria & requirements, enabling the enterprise to obtain the necessary license to employ them. MOWAAMAH Outstanding Woman.. Outstanding AcedrA.. At AcedrA, we strive to create a fair and equitable workplace where every employee has the same opportunity for career advancement. We recognize that women often face unique challenges in the professional world and are committed to creating programs that help them develop and thrive in their careers. Our special programs equip women with the tools they need to confidently pursue their ambitions and contribute their talent to our company. We are proud to be an equal opportunity employer and continue to work towards making AcedrA a welcoming place for all genders. We believe that diversity of thought and experience is essential in creating innovative solutions and fostering an environment where everyone can reach their full potential. With this in mind, we are committed to creating programs that provide professional development and support for women, so they can make their mark in the workplace. Discover LIFE@AcedrA Vision 2030 recognizes that a successful, modern nation must encourage and empower all members of society, including women. We adhere to several governmental programs to empower women at work : QURRAH QIYADYAT Philanthropy & Charity We are dedicated to partnering with charitable foundations, initiatives, and programs that align with our values of giving back to our local and global community. Through these partnerships, we are able to assist those in need and help create a better future. AcedrA is passionate about giving back and we are committed to making an impact through our donations, volunteer efforts, advocacy campaigns, and other initiatives. We will continue to strive towards creating a more equitable world for all. Join Us and Enjoy Contributing to the Community We believe in giving back to our community. That's why we are committed to supporting charities that provide care and support for orphans. We invite you to join us in our mission and help make a difference in the lives of these children. E very donation goes a long way, so please consider donating today. Together, we can create a brighter future for these little ones! ENSAN We also participate in medical donation campaigns for international destinations and we are proudly registered within the database of the King Salman Relief Centre Humanitarian Aid and Relief Centre which is striving to become a leading center for relief and humanitarian activities and to transfer the values of the kingdom to the world. King Salman Humanitarian Aid and Relief Centre EKHAA Every day brings new opportunities to be more environmentally responsible, and every action counts. It's up to us to make sure our planet is healthy and thriving. let's do our part! Today Passionné de contribuer à la communauté et à l'environnement. Joignez-vous à nos efforts maintenant! Prénom Nom de famille E-mail Sujet Tapez votre message ici... Nous faire parvenir Merci d'avoir soumis ! Governance Board of Directors

Titre de la page Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer à modifier le contenu et assurez-vous d'ajouter tous les détails ou informations pertinents que vous souhaitez partager avec vos visiteurs. Bouton From Saudi Arabia to the whole World Saudi Arabia is the largest country in the Middle East, it has a population of over 33 million people and is the only Arab nation to be part of the G20 group of developed countries. The economy of Saudi Arabia has been diversifying in recent years to include, in addition to oil and gas; sectors such as healthcare, education, and retail. Despite the global pandemic, the country is still predicted to be one of the fastest-growing economies in 2021. Saudi Arabia is also home to the two holiest cities in Islam: Mecca, the birthplace of Prophet Muhammad, and Medina. The Kingdom is a major cultural center in the Islamic world with many museums and sites such as Madain Saleh which have been designated as UNESCO World Heritage Sites. In addition to its rich cultural heritage, Saudi Arabia offers visitors stunning natural landscapes such as deserts, oases, and mountains. It is also home to a variety of wildlife, including Arabian leopards and sand cats. The country also features some of the world's most luxurious resorts, offering travelers an unforgettable experience. With so much to explore and experience, it’s no wonder why Saudi Arabia is quickly becoming one of the world’s top tourist destinations. Whether it’s to marvel at ancient architecture, explore stunning landscapes, or enjoy the modern amenities offered by luxury resorts, visitors are sure to find something for everyone in this vibrant country. 1 st Confidence in the performance of the Gov 2021 60.2 % Non-oil sector's contribution to GDP in Q2 2021 +8 billion USD Pharmaceutical market size in 2022 2.60 % expected GDP growth in 2021 58.2 % of population under the age of 35 +6 billion USD Medical technology market size in 2022 5 th in GDP per capita (PPP) among G20 countries 100 % of the population will be covered by the unified digital medical records system by 2025 5.8 % CAGR healthcare services sector growth from 2017 to 2029 Focusing on the Middle East and North Africa region (MENA) The middle east and north Africa region is a melting pot of vibrant cultures, lush landscapes and bustling cities. From the ancient sands of Egypt to the glistening waters of Lebanon, this diverse region has something for everyone. It’s no wonder why it's become such an incredibly popular destination for travelers around the world. The middle east and north Africa region are also one of the most attractive investment destinations in the world. With its abundance of natural resources, strong economic growth potential, and openness to foreign direct investments, this area of the globe is ripe with opportunities. As the middle east and north Africa region continues to open up, it is becoming increasingly attractive for investments. The region is rich in natural resources and its economies are growing rapidly. With its increasing openness to foreign direct investments, a diverse range of industries from oil and gas to tech startups have found success in the middle east and north Africa region. This is why the middle east and north Africa region is becoming such an appealing destination for businesses and investors alike. 21 countries as per the world bank and could be stretched to 27 countries 3 % of global pharmaceutical market size in value +61 billion USD Pharmaceutical market size expected in 2026 comparing to 30 billion USD in 2020 6 % of the world population, about the same as the European Union population 60 % of population under the age of 35 +22 billion USD Medical Device market size expected n 2027 comparing to 16.6 billion USD in 2019 1 st in GDP growth comparing to the world average in 2022 3.5 million Orphan and Rare Diseases prevalence in the MENA region in 2021 4.5 % CAGR Pharmaceutical sector growth from 2021 to 2026 AcedrA Connecting the Dots We provide our clients with a comprehensive understanding of the economic, cultural, and regulatory dynamics of the Middle East and North Africa region. Our insights include an in-depth analysis of on-the-ground trends, market developments, and industry-related news - allowing our clients to make informed decisions. As one of Saudi Arabia's leading operators for regional business, our team is made up of experienced professionals who have an intimate understanding of the region, enabling us to provide tailored solutions that meet our clients' needs. We are committed to connecting our clients with the right healthcare institutions and centers in the Middle East and North Africa region, helping them to succeed in their business endeavors. With our support and expertise, we are confident that you will be able to make the most of your potential in this dynamic part of the world. Get in Touch with Us Today Section titre Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer à modifier le contenu et assurez-vous d'ajouter tous les détails ou informations pertinents que vous souhaitez partager avec vos visiteurs. Managed Markets Partnered Markets Ouvrir ng heures Du soleil de jour à jeudi : de 8h00 (GMT+3) à 17h00 (GMT+3) Coordonnées Adresse ss: Platinum Centre, Office 303, Salah Aldin Al Ayyubi Street, Al Zahraa, PO Box: 12811-2071, Al Riyad, Arabie Saoudite Téléphone : +966 11 400 0036 | +966 11 400 0032 Télécopie : +966 11 400 0059 Courriel : info@acedrarx.com Horaires d'ouvertures Du dimanche au jeudi : 08h00 (GMT+3) à 17h00 (GMT+3) Coordonnées Adresse : Bâtiment numéro 5425, Waraqa Ibn Nawfal Street, The Industrial City of Melhem, Al Horaimla, PO Box : 15458-9484, Al Riyad, Arabie saoudite Téléphone : +966 11 400 0036 Télécopie : +966 11 400 0059 Courriel : logistique@acedrarx.com Connect AcedrA Headquarter Al Riyadh, Saudi Arabia Top Management, BoD, Centralized Operations, Financial Operations, HR, Business Support Connect Warehouse & Logistics Centre Riyadh North, Saudi Arabia Logistics & warehousing, Storage center, Dispatching center, Labelling & Packaging, 3PL Connect UAE Office Dubai, United Arab Emirates Marketing, Market Access, Business Development, Distribution, Regulatory Affairs, Medical Affairs Connect Tunisia Office Tunis, Tunisia North Africa Development, Distribution, Regulatory Affairs, Marketing, Market Access, Medical Affairs Connect Capabilities Regulatory Support

Modern Slavery and Human Trafficking Statement Les sites de médias sociaux nous permettent d'interagir et de communiquer avec nos clients d'une manière que les sites Web traditionnels ne peuvent pas. Nous utilisons les médias sociaux dans le cadre de notre engagement envers la transparence et pour fournir des informations à nos clients et parties prenantes. Nous sommes présents sur plusieurs plateformes de médias sociaux que vous pouvez utiliser pour vous tenir au courant des nouvelles et des activités d'AcedrA. Ces comptes sont soumis à nos directives communautaires, qui peuvent être consultées ci-dessous. Nous vous encourageons à interagir en nous suivant et en discutant de sujets pertinents. Cependant, AcedrA s'attend à ce que les abonnés respectent les autres. Veuillez lire attentivement ces règles simples et revenez de temps en temps car elles peuvent changer : En raison des exigences légales uniques dans lesquelles nous opérons, nous ne pouvons pas offrir de conseils médicaux ou autrement nous engager dans une promotion ou une discussion sur des produits ou des options de traitement spécifiques - distribués par nous ou par d'autres sociétés - sur nos propriétés sociales. Votre médecin reste votre meilleure source d'information sur les médicaments et traitements autorisés dans votre pays de résidence. Le contenu suivant n'est pas acceptable et peut faire l'objet d'une suppression ou bloquer les utilisateurs qui enfreignent ces conditions : Contenu qui inclut des propos blasphématoires, diffamatoires, calomnieux et offensants ou dégradants (y compris des images, des vidéos et des liens) Contenu trompeur, frauduleux ou trompeur Commentaires désobligeants ou menaçants sur les autres Contenu sur des produits spécifiques ou des options de traitement Messages excessivement répétitifs et/ou perturbateurs pour la communauté ou de nature SPAM Les publications contenant des informations exclusives, confidentielles, sensibles ou non publiques sur ou liées à AcedrA ou à toute autre personne ou entreprise ne sont pas acceptables. De même, les postes liés à des projets en cours ou futurs dans lesquels AcedrA est impliqué ne sont pas acceptables Les messages contenant des liens, y compris ceux vers des vidéos, n'appartenant pas à AcedrA Messages partageant des informations personnelles vous concernant et toute connexion à AcedrA Publie des messages vendant ou sollicitant des conseils, des services ou des produits d'un individu ou d'un tiers Veuillez garder à l'esprit qu'AcedrA ne vérifie, ne représente ni n'approuve les opinions ou informations exprimées par des organisations tierces ou des individus qui publient du contenu sur les propriétés sociales d'AcedrA et que tout contenu publié par une personne autre qu'AcedrA est la responsabilité de l'auteur et non Acedr A. Tous les commentaires faits par les utilisateurs, y compris les employés actuels ou anciens d'AcedrA, reflètent leurs pensées et positions individuelles. Ceux-ci ne sont pas approuvés par AcedrA ou un représentant d'AcedrA en tant qu'entreprise. Les propriétés sociales d'AcedrA ne sont pas des endroits où signaler des événements ou des réactions indésirables médicaux ou des plaintes concernant les produits. Si vous pensez avoir subi des effets indésirables ou des réactions indésirables à un produit distribué par AcedrA, veuillez consulter immédiatement votre médecin ou votre pharmacien. Si vous pensez avoir subi un événement indésirable lors de l'utilisation d'un produit distribué par AcedrA, veuillez contacter le service de pharmacovigilance d'AcedrA(Cliquez ici) ou envoyer un e-mail àpharmacovigilance@acedrarx.com . Si vous incluez accidentellement un rapport d'événement indésirable dans votre message, AcedrA devra peut-être vous contacter pour obtenir plus d'informations. Cela est dû aux exigences réglementaires concernant les rapports de sécurité. Nous n'avons pas pour objectif de stocker l'identifiant unique, l'adresse e-mail ou d'autres informations personnelles de votre profil de réseau social. Cependant, en cas d'événement indésirable ou de problème de produit, nous aurions besoin de stocker des informations vous concernant, telles que votre nom ou votre emplacement. Ces informations doivent obligatoirement être soumises au service de pharmacovigilance d'AcedrA et/ou aux autorités réglementaires. Les sujets médicaux et de santé peuvent être discutés sur les propriétés sociales d'AcedrA mais ne doivent pas être interprétés comme des conseils médicaux. Nous pouvons occasionnellement partager des liens vers des sites tiers lorsque nous pensons que vous trouverez les informations utiles. Cependant, veuillez noter que cela ne constitue en aucun cas une approbation officielle de l'individu, du site ou de l'entreprise. Nous ne sommes pas responsables des termes et conditions, de la politique de confidentialité ou du contenu de tout site Web accessible via des liens ou des références dans nos propriétés sociales. Veuillez noter que nous pouvons ne plus suivre un utilisateur qui change radicalement sa mission et ses objectifs, ou qui, selon nous, enfreint les directives de notre communauté. Nous voulons que tous les fans et followers d'AcedrA se sentent libres de partager. Cependant, étant donné que nos profils sur les réseaux sociaux sont publics et que tout le monde peut interagir avec nous, nous ne pouvons être tenus responsables des opinions exprimées autres que les nôtres. Veuillez lire à vos risques et périls et sachez que, pendant que nous écoutons, nous ne pouvons pas certifier ou valider l'exactitude des déclarations faites par les fans et la communauté sociale d'AcedrA, et les opinions exprimées par les utilisateurs externes sur nos propriétés de médias sociaux ne sont pas représentatives des opinions. d'Acedr A. Nous nous réservons le droit de supprimer à tout moment l'une de nos plateformes de médias sociaux et leur contenu. Veuillez vérifier souvent les mises à jour, car nous nous réservons le droit, à notre seule discrétion, de modifier ces directives communautaires à tout moment. Votre utilisation de nos propriétés de médias sociaux indique votre acceptation de toute révision de ces conditions. De plus, bien que ces règles couvrent les situations les plus courantes, elles ne peuvent pas tout anticiper. Par conséquent, AcedrA peut prendre toutes les mesures qu'elle juge appropriées pour s'assurer qu'un site particulier n'est pas perturbé ou abusé de quelque manière que ce soit. En plus de la politique de confidentialité et des conditions d'utilisation de la plate-forme de médias sociaux tierce, votre utilisation de nos propriétés sociales est régie par AcedrA's Conditions d'utilisation et Politique de confidentialité et de cookies . AcedrA Statement on Modern Slavery & Human Trafficking AcedrA Code of Conduct

Acedr UN F ROM Cèdre Le nom d'AcedrA vient du nom d'un arbre majestueux "Cèdre", très célèbre au Moyen-Orient et dans la région méditerranéenne. Le grand cèdre sera à jamais profondément enraciné dans les histoires anciennes du monde. De son bois solide et polyvalent à son feuillage persistant parfumé et médicinal, le cèdre a soutenu de nombreux peuples différents avec ses innombrables utilisations pendant des millénaires. Le cèdre est traditionnellement connu pour traiter les maladies difficiles. Ainsi, conçu AcedrA! Notre ADN ! Cliquez ici pour découvrir De l'Arabie Saoudite _cc781905-5cde-3194 au monde entier Depuis sa fondation en 2017, AcedrA a rejoint les efforts du royaume via "Vision 2030" pour renforcer le secteur économique non pétrolier et transformer l'Arabie saoudite en une icône mondiale en termes de recherche scientifique et de développement. L'un des trois principaux piliers de la vision 2030, la création d'une "société dynamique" où permettre une vie pleine et saine grâce à l'amélioration des services de santé et de la qualité de vie dans les villes saoudiennes sont les objectifs stratégiques. Cliquez ici pour en savoir plus sur Vision 2030 Représenter le conseil des actionnaires Conseil d'administration Lire la suite Des experts avisés et dévoués Équipe de direction Lire la suite Construit sur les meilleures pratiques de gouvernance Gouvernance Lire la suite Fait partie de notre politique ESG Responsabilité sociale des entreprises Lire la suite Home Our DNA

Titre de la page Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer à modifier le contenu et assurez-vous d'ajouter tous les détails ou informations pertinents que vous souhaitez partager avec vos visiteurs. Bouton Section titre Chaque site Web a une histoire et vos visiteurs veulent entendre la vôtre. Cet espace est une excellente occasion de donner un aperçu complet de qui vous êtes, de ce que fait votre équipe et de ce que votre site a à offrir. Double-cliquez sur la zone de texte pour commencer à modifier votre contenu et assurez-vous d'ajouter tous les détails pertinents que vous souhaitez que les visiteurs du site connaissent. Si vous êtes une entreprise, parlez de vos débuts et partagez votre parcours professionnel. Expliquez vos valeurs fondamentales, votre engagement envers les clients et comment vous vous démarquez de la foule. Ajoutez une photo, une galerie ou une vidéo pour encore plus d'engagement. Investors Newsroom

Terms of Use This website (the “Site”) is provided by AcedrA for the convenience of visitors to the Site. Nothing on the Site should be construed as an offer to form a binding contract, or as granting any license or transfer of intellectual property. Your use of the Site is at your own risk. Notwithstanding any other provision herein, AcedrA reserves the right, in the event of a violation of these terms and conditions, to protect its rights, property, and interests to the maximum extent of the law. Please read these terms of use carefully before using this website. These terms of use describe the terms and conditions applicable to your use of AcedrA Pharmaceutical Company’s (“AcedrA”) website. By using this website, you signify your assent to these Terms of Use. If you do not agree to all of these Terms and Conditions of Use, do not use this website. AcedrA may modify this website and the rules and regulations governing its use, at any time. Modifications will be posted on the website, so please check back when you use the website. By continuing the use of the website after such changes are posted you will be accepting such changes. THIS WEBSITE DOES NOT PROVIDE MEDICAL OR PROFESSIONAL SERVICES ADVICE The content on this website is intended to be a general information resource in regard to the subject matter covered but is provided solely on an “as is” and “as available” basis as noted on these Terms of Use. You are encouraged to confirm the information contained herein with other sources and to review the information carefully with your professional healthcare provider. AcedrA is not engaged in rendering medical or similar professional services or advice via this website, and the information provided is not intended to replace medical advice offered by a physician. If you desire or need such services or advice, you should consult a professional healthcare provider. You should not construe AcedrA’s publication of this content as an endorsement by AcedrA of the views expressed herein, or any warranty or guarantee of any strategy, recommendation, treatment, action, or application of medication or preparation made by the author of the content. Scope of Use AcedrA invites you to view, use and download a single copy of this website for your informational, non-commercial use. Except as otherwise provided on this page, no part of any content or software on this website may be copied, downloaded, or stored in a retrieval system for any other purpose, nor may it be redistributed for any purpose, without the expressed written permission of AcedrA. You understand that AcedrA may discontinue, change or restrict your use of this website for any reason without notice. By using this website, you represent that you are at least Eighteen (18) years old. No Warranties All content on this website is provided to you on an “as is” or “as available” basis without warranty of any kind either express or implied, including but not limited to any implied warranties of merchantability, fitness for a particular purpose, accuracy, and non-infringement. AcedrA makes no warranty as to the accuracy, completeness, currency, or reliability of any content available through this website. You are responsible for verifying any information before relying on it. Use of the website and the content available on the website is at your sole risk. AcedrA makes no representations or warranties that use of the website will be uninterrupted or error-free. You are responsible for taking all necessary precautions to ensure that any content you may obtain from the website is free of viruses. The above exclusions may not apply in jurisdictions that do not allow the exclusion of certain implied warranties. Limitation of Liability and No Duty to Update Your use of the website or any content on the website is at your own risk. AcedrA specifically disclaims any liability, whether based in contract, tort, strict liability, or otherwise, for any direct, indirect, incidental, consequential, or special damages arising out of or in any way connected with access to or use of the website, even if AcedrA has been advised of the possibility of such damages, including but not limited to reliance by any party on any content obtained through the use of the website, or that arises in connection with mistakes or omissions in, or delays in transmission of, information to or from the user, interruptions in telecommunications connections to the website or viruses, whether caused in whole or in part by negligence, acts of Allah, telecommunications failure, theft or destruction of, or unauthorized access to the website, or related information or programs. AcedrA does not warrant that the functions contained in this website are free of computer viruses or other harmful components. Although the content of this website is updated periodically, AcedrA does not have a duty to update the information contained in this website, and AcedrA will not be liable for any failure to update such information. AcedrA does not assume any responsibility or liability for the accuracy, completeness, reliability, or usefulness of the information disclosed or accessed through this website. It is your responsibility to verify any information contained in this website before relying upon it. Intellectual Property Rights All content of this website is protected by the Saudi Authority for Intellectual Property (SAIP) and foreign copyright laws. You may not copy, modify, upload, download, post, transmit, republish, or distribute any of the content, including without limitation the code, contained in this website without our prior written permission except for your own personal, non-commercial purposes. Except as provided in the preceding sentence, nothing contained in this website shall be construed as granting a license or other rights under any patent, trademark, copyright, or other intellectual property of AcedrA or any third party. Unauthorized use of any AcedrA trademark, service mark, or logo may be a violation of federal and state trademark laws. Links This website may contain links to websites operated by other parties. The linked sites are not under the control of AcedrA, and AcedrA is not responsible for the content available on any other Internet sites linked to this website. Such links do not imply AcedrA’s endorsement of the material on any other site and AcedrA disclaims all liability about your access to such linked websites. AcedrA provides links to other Internet sites as a convenience to users, and access to any other Internet sites linked to this website is at your own risk. Unless otherwise set forth in a written agreement between you and AcedrA, you must adhere to AcedrA’s linking policy as follows: (i) any link to this website must be a text-only link clearly marked “acedrarx.com” or “AcedrA website”; (ii) the appearance, position, and other aspects of the link may not be such as to damage or dilute the goodwill associated with AcedrA’s names and trademarks; (iii) the link must “point” to the home page (e.g. www.acedrarx.com ) and not to other pages within the website; (iv) the appearance, position, and other attributes of the link may not create the false appearance that your organization or entity is sponsored by, affiliated with or associated with AcedrA; (v) when selected by a user, the link must display the website on full screen and not within a “frame” on the linking website; and (vi) AcedrA reserves the right to revoke its consent to the link at any time and at its sole discretion. Location and Governing Law This website is operated by AcedrA from its offices in Riyadh, the Kingdom of Saudi Arabia. The law of the Kingdom of Saudi Arabia shall govern these terms and conditions, without reference to its choice of law rules. AcedrA makes no representation that the information on the website is appropriate or available for use in other locations, and access to the AcedrA website from territories where the content of the AcedrA website may be illegal is prohibited. Those who choose to access the AcedrA website from other locations do so on their own initiative and are responsible for compliance with applicable local laws. Severability If any provision of these Terms of Use is held invalid or unenforceable by any court of competent jurisdiction, the other provisions of these Terms of Use shall remain in full force and effect. Any provision of these Terms of Use held invalid or unenforceable only in part or degree will remain in full force and effect to the extent not held invalid or unenforceable. The parties further agree to replace the such invalid or unenforceable provision of these Terms of Use with a valid and enforceable provision that will achieve, to the extent possible, the economic, business, and other purposes of the such invalid or unenforceable provision. Violations and additional policies AcedrA reserves the right to seek all remedies available at law and in equity for violations of the rules and regulations set forth in this website, including the right to block access from a particular Internet address to the website. Questions If you have any questions about these Terms and Use, please contact the relevant individual listed in the Contact Us section of this website. Those Terms of Use are effective as of February 14th, 2023 Riyadh, Saudi Arabia media@acedrarx.com

Prestations de service Ceci est votre page de services. C'est une excellente occasion de fournir des informations sur les services que vous fournissez. Double-cliquez sur la zone de texte pour commencer à modifier votre contenu et assurez-vous d'ajouter tous les détails pertinents que vous souhaitez partager avec les visiteurs du site. Que vous offriez plusieurs services, cours ou programmes, vous pouvez modifier cet espace pour l'adapter aux besoins de votre site Web. Double-cliquez simplement sur cette section pour ouvrir le gestionnaire de contenu et modifier le contenu. Expliquez ce que chaque élément implique et ajoutez des photos ou des vidéos pour encore plus d'engagement. AcedrA , the champion of EAP in the MENA region We are the champion of EAP in the MENA region with various successful track records in many institutions. Early Access Programs allow us to collect real-world data (RWD) on the safety and efficacy of our drugs in a larger patient population, which can help our partners to continue developing new treatments. By setting up Early Access Programs, we are able to provide life-changing treatments while also helping to advance medical research. The programs that we can manage and provide services are: - Named Patient Programs (NPP): either approved (Post-Approval ) or clinical assets (Pre-Approval ) with the legal ability to be exported to the MENA region - Compassionate Use Programs (CU): granting access under special conditions to - Clinical Supply Programs (CS): we can provide end-to-end solutions for clinical supply including clinical packaging, clinical labeling, comparator sourcing services, etc. Named Patient Programs Pre-Approval NPP and Post-Approval NPP are effective ways for our partners to provide early access to treatments that may not be otherwise available. By taking part in such programs, we can ensure that our products are getting into the hands of those who need them most and gain valuable insight into how their treatments are being used. It is clear that we must continue to explore new ways of providing early access in order to keep up with the changing needs of patients and make sure that no one is left behind. EAP@acedrarx.com Compassionate Use Programs Compassionate use programs are an important reminder that we have a responsibility to use our expertise and resources to make the world a better place. Compassionate use programs can be the difference between life and death for some, and we are in a unique position to help those in need. By providing access to treatments before they become widely available, our partners can make a huge difference in the lives of those who need it most. EAP@acedrarx.com Clinical Supply Programs These programs involve the strategic coordination between the management of manufacturing, distribution, and storage, which needs to ensure an adequate supply of medications while maintaining cost-effectiveness. We can save time, money, and resources while providing the best possible care to our patients. This includes also taking care about the best alternative to source for a clinical trial or study, the adequate packaging and labeling. EAP@acedrarx.com Obtenir un devis Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer à modifier le contenu. Prénom Nom de famille E-mail Company Envoyer Merci d'avoir soumis ! Licensing Regulatory & Medical Affairs